Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023

BUY
$0.92 - $96.0 $1,564 - $163,200
1,700 Added 96.59%
3,460 $3,000
Q4 2021

Feb 11, 2022

BUY
$5.46 - $9.69 $6,060 - $10,755
1,110 Added 170.77%
1,760 $11,000
Q2 2021

Aug 09, 2021

BUY
$3.39 - $6.98 $2,203 - $4,537
650 New
650 $4,000

Others Institutions Holding MYMD

About MyMD Pharmaceuticals, Inc.


  • Ticker MYMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,470,000
  • Market Cap $67.5M
  • Description
  • MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the causes of disease. The company is developing MYMD-1, a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and o...
More about MYMD
Track This Portfolio

Track Sandy Spring Bank Portfolio

Follow Sandy Spring Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sandy Spring Bank, based on Form 13F filings with the SEC.

News

Stay updated on Sandy Spring Bank with notifications on news.